4 completed, 1 recruiting, 1 terminated, 1 withdrawn. 7 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Completed 4, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Use of Long-acting Tacrolimus in Lung Transplant Recipients Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate Mofetil Hydrochloride - Lung Transplant; Complications | Early Phase 1 | Recruiting | Vanderbilt University Medical Center | 48 | 2023-12-01 | 2026-05-15 |
| Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies Bortezomib, Busulfan, Cyclophosphamide - Beta Thalassemia Major, Sickle Beta 0 Thalassemia | Early Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2020-12-29 | 2024-10-24 | |
| Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Primary Myelofibrosis, Secondary Myelofibrosis | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 3 | 2018-01-31 | 2020-10-14 |
| A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy, Keratinocyte Growth Factor, Alemtuzumab - Neuroepithelial Tumor, Solid Tumor | Early Phase 1 | Terminated | Montefiore Medical Center | 1 | 2015-09-01 | 2017-08-17 |
| Intra-Osseous Co-Transplant of UCB and hMSC cyclophosphamide, fludarabine phosphate, total-body irradiation - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 6 | 2015-07-22 | 2020-12-04 |
| Combination Therapy Using Cellcept and Rebif in RRMS mycophenolate mofetil (Cellcept), human interferon beta 1a (Rebif) - Multiple Sclerosis | Early Phase 1 | Completed | Aaron Boster | 31 | 2006-08-01 | 2012-11-15 |
| MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression Mycophenolate Mofetil - Transplantation, Renal, Immunosuppression | Early Phase 1 | Completed | University of Florida | 22 | 2005-08-01 | 2012-06-20 |
Primary Myelofibrosis (2) · Anemia, Sickle Cell (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Myelodysplastic Syndromes (1) · Neoplasms (1) · Neoplasms, Neuroepithelial (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · beta-Thalassemia (1)
M.D. Anderson Cancer Center (2) · Aaron Boster (1) · Case Comprehensive Cancer Center (1) · Montefiore Medical Center (1) · University of Florida (1) · Vanderbilt University Medical Center (1)
United States (6)
Aaron L Boster, MD (1) · Anil J Trindade, MD (1) · Herwig-Ulf Meier-Kriesche, MD (1) · Kris M Mahadeo (1) · Kris M Mahadeo, MD,MPH (1) · Leland Metheny, MD (1) · Stefan O Ciurea (1)
P30CA016672 (1), P30CA043703 (1)